The case that Ozempic (NVO) and other GLP-1 medications could help people with substance use disorders is getting stronger.

This is just a sneak peek at the thousands of consumer insights available to CivicScience clients. Discover more data. The ...

New, popular injectable weight loss drugs — GLP-1 drugs — are highly effective at reducing obesity and, probably, the health ...

GLP-1 receptor agonists and similar drugs may protect people with opioid or alcohol use disorder from opioid overdose and ...

A sign at a pharmacy in Jongno District, central Seoul, says that Wegovy, a weight-loss drug, is available for sale on ...

Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid ...

These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.

The British government announced a multimillion dollar pharmaceutical partnership with Eli Lilly, including a trial that will ...

Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, ...

Danish drugmaker Novo Nordisk has made billions of dollars from its GLP-1s, including pills and injectable drugs like Ozempic ...

Newer weight loss drugs are cost effective in the long term only when combined with bariatric weight loss surgery, according ...

New popular weight-loss and anti-diabetes drugs may reduce the rate of opioid overdose or alcohol intoxication in people with ...